Hugosson J - Search Results

1

The story of the European Randomized Study of Screening for Prostate Cancer.

Schröder FH, Denis LJ, Roobol M, Nelen V, Auvinen A, Tammela T, Villers A, Rebillard X, Ciatto S, Zappa M, Berenguer A, Paez A, Hugosson J, Lodding P, Recker F, Kwiatkowski M, Kirkels WJ; ERSPC. Schröder FH, et al. Among authors: hugosson j. BJU Int. 2003 Dec;92 Suppl 2:1-13. doi: 10.1111/j.1464-410x.2003.04389.x. BJU Int. 2003. PMID: 14983946 Review. No abstract available.

2

Influence of benign prostatic hyperplasia, testosterone and age on serum levels of prostate specific antigen.

Aus G, Bergdahl S, Hugosson J, Lodding P, Norlén L. Aus G, et al. Among authors: hugosson j. Scand J Urol Nephrol. 1994 Dec;28(4):379-84. doi: 10.3109/00365599409180517. Scand J Urol Nephrol. 1994. PMID: 7533925

3

Reference range of prostate-specific antigen after transurethral resection of the prostate.

Aus G, Bergdahl S, Frösing R, Lodding P, Pileblad E, Hugosson J. Aus G, et al. Among authors: hugosson j. Urology. 1996 Apr;47(4):529-31. doi: 10.1016/S0090-4295(99)80489-0. Urology. 1996. PMID: 8638362

4

Primary carcinoid tumour with ossification masquerading as calyx stone in a horseshoe kidney.

Lodding P, Hugosson J, Hansson G. Lodding P, et al. Among authors: hugosson j. Scand J Urol Nephrol. 1997 Dec;31(6):575-8. doi: 10.3109/00365599709030667. Scand J Urol Nephrol. 1997. PMID: 9458520

5

Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.

Lodding P, Aus G, Bergdahl S, Frösing R, Lilja H, Pihl CG, Hugosson J. Lodding P, et al. Among authors: hugosson j. J Urol. 1998 Mar;159(3):899-903. J Urol. 1998. PMID: 9474178

6

Lower urinary tract symptoms. A comparison of micturition symptoms in patients scheduled for transurethral prostatic resection and outpatients of both sexes referred for non-urological complaints.

Bergdahl S, Aus G, Lodding P, Norlén L, Hugosson J. Bergdahl S, et al. Among authors: hugosson j. Scand J Urol Nephrol. 1998 Feb;32(1):20-5. doi: 10.1080/003655998750014639. Scand J Urol Nephrol. 1998. PMID: 9561569

7

Transrectal ultrasound with separate measurement of the transition zone volume predicts the short-term outcome after transurethral resection of the prostate.

Bergdahl S, Aus G, Lodding P, Norlén L, Hugosson J. Bergdahl S, et al. Among authors: hugosson j. Urology. 1999 May;53(5):926-30. doi: 10.1016/s0090-4295(99)00053-9. Urology. 1999. PMID: 10223485 Clinical Trial.

8

Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).

Kranse R, Beemsterboer P, Rietbergen J, Habbema D, Hugosson J, Schröder FH. Kranse R, et al. Among authors: hugosson j. Prostate. 1999 Jun 1;39(4):316-22. doi: 10.1002/(sici)1097-0045(19990601)39:4<316::aid-pros14>3.0.co;2-o. Prostate. 1999. PMID: 10344223 Clinical Trial.

9

Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden.

Hugosson J, Aus G, Becker C, Carlsson S, Eriksson H, Lilja H, Lodding P, Tibblin G. Hugosson J, et al. BJU Int. 2000 Jun;85(9):1078-84. doi: 10.1046/j.1464-410x.2000.00679.x. BJU Int. 2000. PMID: 10848699

10

Screening and early detection of prostate cancer.

Schröder FH, Alexander FE, Bangma CH, Hugosson J, Smith DS. Schröder FH, et al. Among authors: hugosson j. Prostate. 2000 Aug 1;44(3):255-63. doi: 10.1002/1097-0045(20000801)44:3<255::aid-pros11>3.0.co;2-i. Prostate. 2000. PMID: 10906743 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters